Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Urology. 2011 Feb;77(2):368-72. doi: 10.1016/j.urology.2010.05.020. Epub 2010 Dec 15.
Recent observations suggest that surgeon volume is associated with lymph node counts during retroperitoneal lymph node dissection (RPLND). We report our contemporary single-surgeon experience with lymph node counts during primary RPLND for nonseminomatous germ cell tumors.
Using the Memorial Sloan-Kettering Cancer Center Testis Cancer Registry, we identified 124 consecutive patients treated with primary RPLND by a single experienced surgeon for nonseminomatous germ cell tumors between 2004 and 2008. Predictors of positive nodes and number of positive nodes were evaluated with logistic and linear regression models adjusting for year of surgery and clinical stage.
Positive lymph nodes were observed in 37 patients (30%), whereas 87 patients (70%) were pN0. Mean total node count was 51 (standard deviation [SD] = 23) during the 5-year study period. Mean node counts for the paracaval, interaortocaval, and paraaortic regions were 8 (SD = 6), 17 (SD = 9), and 26 (SD = 15), respectively. In a multivariate analysis, higher total node count was significantly associated with finding positive nodes (odds ratio = 1.02 for each additional node counted; P = .037) and finding multiple positive nodes (linear regression coefficient = 0.04 for each additional node counted; P = .004). Year of surgery (P < .001) was associated with higher total node counts, whereas clinical stage and pathologist were not (P > .5 for each).
The average total node count for a primary RPLND by an experienced surgeon is approximately 50 nodes, with nearly half of the nodes originating in the paraaortic region. These results will be useful when assessing the adequacy of lymph node dissections for testis, renal, and upper tract urothelial malignancies.
最近的观察结果表明,外科医生的手术量与腹膜后淋巴结清扫术(RPLND)中的淋巴结计数有关。我们报告了我们在单一外科医生进行的原发性 RPLND 中对非精原细胞瘤生殖细胞肿瘤的淋巴结计数的当代经验。
使用 Memorial Sloan-Kettering Cancer Center Testis Cancer Registry,我们从 2004 年至 2008 年间,确定了由一位经验丰富的外科医生对 124 例非精原细胞瘤生殖细胞肿瘤患者进行的原发性 RPLND 治疗的连续患者。使用逻辑回归和线性回归模型评估阳性淋巴结和阳性淋巴结数量的预测因素,调整手术年份和临床分期。
37 例(30%)患者观察到阳性淋巴结,而 87 例(70%)患者为 pN0。在 5 年研究期间,总淋巴结计数的平均值为 51(标准差[SD] = 23)。腹主动脉旁、主动脉旁和主动脉旁区域的平均淋巴结计数分别为 8(SD = 6),17(SD = 9)和 26(SD = 15)。在多变量分析中,较高的总淋巴结计数与发现阳性淋巴结(每个额外计数的淋巴结的优势比为 1.02;P =.037)和发现多个阳性淋巴结(每个额外计数的淋巴结的线性回归系数为 0.04;P =.004)显著相关。手术年份(P <.001)与较高的总淋巴结计数相关,而临床分期和病理学家则无相关性(每种情况 P >.5)。
经验丰富的外科医生进行原发性 RPLND 的平均总淋巴结计数约为 50 个,其中近一半的淋巴结起源于主动脉旁区域。这些结果在评估睾丸,肾脏和上尿路尿路上皮恶性肿瘤的淋巴结清扫术的充分性时将非常有用。